Adaptive trial in severe pneumonia Coronavirus COVID-19 (REMAP-CAP-COVID-19) : Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia Coronavirus COVID-19 (REMAP-CAP-COVID-19) - REMAP-CAP
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
WHO International Clinical Trials Registry Platform - (2020) vom: 06. Apr. Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Unbestimmt |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 27-03-2020, Last updated: 2022-11-24 |
|---|
| ICTRP ID: |
EUCTR2015-002340-14-FR |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
WHO004503236 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WHO004503236 | ||
| 003 | DE-627 | ||
| 005 | 20230425182750.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210507s2020 xx |||||o 00| ||und c | ||
| 035 | |a (DE-627)WHO004503236 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)EUCTR2015-002340-14-FR | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)REMAP-CAP | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)NCT02735707 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)2015-002340-14-NL | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a und | ||
| 245 | 1 | 0 | |a Adaptive trial in severe pneumonia Coronavirus COVID-19 (REMAP-CAP-COVID-19) |b Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia Coronavirus COVID-19 (REMAP-CAP-COVID-19) - REMAP-CAP |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 27-03-2020, Last updated: 2022-11-24 | ||
| 650 | 4 | |a Medical Condition: Severe Community Acquired Pneumonia MedDRA version: 20.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Phase: Phase 3 | |
| 650 | 4 | |a Recruitment Status: Authorised-recruitment may be ongoing or finished | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2020) vom: 06. Apr. |
| 773 | 1 | 8 | |g year:2020 |g day:06 |g month:04 |
| 856 | 4 | 0 | |u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002340-14 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2020 |b 06 |c 04 | ||